COMMUNIQUÉS West-GlobeNewswire

Virbac : Déclaration d'actions et droits de vote Avril 2019
10/05/2019
DECLARATION D’ACTIONS ET DE DROITS DE VOTE Informations relatives au nombre total de droits de vote et au nombre d’actions composant le capital (Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers) [...]
Ambu A/S: Ambu appoints new CEO
10/05/2019
Ambu’s board of directors has appointed Juan-José Gonzalez as the new CEO, effective May 15, 2019, to replace Lars Marcher who resigns from his position. Jens Bager, Chairman of the Ambu Board of Directors, comments, “ [...]
GENFIT: Ordinary Shareholder’s Meeting of June 13, 2019 – Availability of Preparatory Documents
10/05/2019
GENFIT: Ordinary Shareholder’s Meeting of June 13, 2019 – Availability of Preparatory Documents Lille (France), Cambridge (Massachusetts, United States), May 10, 2019 – GENFIT (Nasdaq and Euronext: GNFT) , a late-stage [...]
GENFIT : Assemblée générale ordinaire du 13 juin 2019 – modalités de mise à disposition des documents préparatoires
10/05/2019
GENFIT : Assemblée générale ordinaire du 13 juin 2019 – modalités de mise à disposition des documents préparatoires Lille (France), Cambridge (Massachusetts, États-Unis), le 10 mai 2019 – GENFIT (Nasdaq et Euronext: [...]
Bone Therapeutics SA: The preliminary documents for the Annual Ordinary General Shareholder Meeting on 12 June 2019 have been made available
10/05/2019
Regulated information Gosselies, Belgium, 10 May 2019, 7 am CEST – BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the bone cell therapy company addressing high unmet medical needs in orthopaedics and bone [...]
Bone Therapeutics SA : Mise à disposition des documents préparatoires à l’assemblée générale ordinaire du 12 juin 2019
10/05/2019
Information réglementée Gosselies, Belgique, le 10 mai 2019, 7h00 CEST - BONE THERAPEUTICS (code Euronext Bruxelles et Paris : BOTHE), société de thérapie cellulaire osseuse qui répond à d’importants besoins médicaux [...]
Acacia Pharma’s BARHEMSYS Significantly Improves Post-operative Nausea & Vomiting (PONV) in Rescue Treatment of Ambulatory Patients
10/05/2019
New post-hoc subset analysis from positive Phase 3 trial selected as part of the Excellence and Innovation Awards to be presented at SAMBA 2019 Cambridge, UK and Indianapolis, US – 10 May 2019: Acacia Pharma Group plc [...]
Genesis HealthCare Reports Solid First Quarter 2019 Results
10/05/2019
KENNETT SQUARE, Pa., May 09, 2019 (GLOBE NEWSWIRE) -- Genesis Healthcare, Inc. (Genesis, or the Company) (NYSE:GEN), one of the largest post-acute care providers in the United States, today announced operating results [...]
Medtronic Enters Into Definitive Agreement to Acquire Titan Spine
09/05/2019
Acquisition Further Accelerates Medtronic's Strategy to Transform Spinal Procedures and Improve Outcomes Through Complete Procedural Solutions DUBLIN - May 9, 2019 - Medtronic plc (NYSE:MDT), a global leader in medical [...]
Adynxx, Inc. Receives Nasdaq Notice of Delisting or Failure to Satisfy an Initial Listing Rule or Standard
09/05/2019
SAN FRANCISCO, May 09, 2019 (GLOBE NEWSWIRE) -- Adynxx, Inc. (Nasdaq:ADYX), a clinical-stage biopharmaceutical company leading the development of transcription factor decoy technology and first-in-class therapeutics for [...]
Checkpoint Therapeutics Reports First Quarter 2019 Financial Results and Recent Corporate Highlights
09/05/2019
NEW YORK, May 09, 2019 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a clinical-stage, immuno-oncology biopharmaceutical company focused on the acquisition, development and [...]
Jamieson Wellness Inc. Announces Voting Results from 2019 Annual Meeting of Shareholders
09/05/2019
TORONTO, May 09, 2019 (GLOBE NEWSWIRE) -- Jamieson Wellness Inc. (“ Jamieson Wellness ” or the “ Company ”) (TSX: JWEL) announced today that each of the nominee directors listed in the management information circular of [...]
FibroGen Reports First Quarter 2019 Financial Results
09/05/2019
Positive topline results from pooled safety analyses of roxadustat Phase 3 global program Completed one year of treatment in Phase 2 trial evaluating pamrevlumab in treatment of non-ambulatory DMD patients Conference [...]
FibroGen Announces Positive Topline Results from Pooled Safety Analyses of Roxadustat Global Phase 3 Program
09/05/2019
MACE/MACE+ endpoints evaluated across CKD patients not on dialysis and on dialysis Superiority in time to first MACE+ versus epoetin alfa in incident dialysis patients SAN FRANCISCO, May 09, 2019 (GLOBE NEWSWIRE) -- [...]
Adamis Pharmaceuticals Announces First Quarter 2019 Financial Results and Business Update
09/05/2019
SAN DIEGO, May 09, 2019 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today announced financial results for the first quarter ended March 31, 2019 and provided a business update. Dr. Dennis J. [...]
Translate Bio Announces First Quarter 2019 Financial Results and Provides Corporate Update
09/05/2019
-- Completed dosing in single-ascending dose portion of Phase 1/2 clinical trial in cystic fibrosis; data expected 3Q19 -- LEXINGTON, Mass., May 09, 2019 (GLOBE NEWSWIRE) -- Translate Bio (Nasdaq: TBIO), a clinical- [...]
BioCryst Completes Phase 1 Clinical Trial of Galidesivir
09/05/2019
RESEARCH TRIANGLE PARK, N.C., May 09, 2019 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) today announced the completion of a randomized, placebo-controlled Phase 1 clinical trial to evaluate [...]
Zafgen Reports First Quarter 2019 Operating and Financial Results
09/05/2019
Recently announced positive results for second cohort of Phase 2 clinical trial of ZGN-1061 Company is currently in the formal regulatory process related to the clinical hold for ZGN-1061; Update still anticipated in Q2 [...]
Cidara Provides Corporate Update and Reports First Quarter 2019 Financial Results
09/05/2019
SAN DIEGO, May 09, 2019 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today reported financial results for the three [...]

Pages